ID Genomics, Inc.

Low cost, highly accurate diagnostics that guide antibiotic prescribing choices in < 45 minutes minimizing antibiotic resistance risk to patients

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded January 2012
  • Employees 3
  • Incorporation Type C-corp
  • Website idgenomics.com

Company Summary

IDGENOMICS (IDG) is developing precision diagnostic tests to guide the best antibiotic choice before the patient leaves the doctor’s office in less than 45 minutes. Our diagnostics "fingerprint" bacteria and assign them to drug resistance "crime families". Our tests will ultimately lead to better patient outcomes and reduced cost to payors. We help antibiotic resistance surveillance by pinpointing outbreaks and improving antibiotic stewardship.

Team

  • Linda Zuckerman

  • Linda Zuckerman
    President and CEO

    Dr. Zuckerman has 15+ yeas experience in bringing novel therapeutics, pharmaceuticals, and medical devices from research to development to licensure at the FDA and other agencies. Her experience includes products for: oncology, autoimmunity, hemostasis, and medical devices. She has a proven track record of successful drug and therapeutic marketing approvals.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free